P. Alexopoulos

发表

[Cognitive reserve and its relevance for the prevention and diagnosis of dementia].

C. Sorg, Hans Förstl, A. Kurz, 2011, Der Nervenarzt.

White matter hyperintensities predict amyloid increase in Alzheimer's disease

Florian Auer, Timo Grimmer, Christian Sorg, 2012, Neurobiology of Aging.

Reduced blood oxygenation level dependent connectivity is related to hypoperfusion in Alzheimer’s disease

C. Sorg, A. Drzezga, C. Zimmer, 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Progressively Disrupted Intrinsic Functional Connectivity of Basolateral Amygdala in Very Early Alzheimer’s Disease

C. Sorg, Hans Förstl, A. Kurz, 2016, Front. Neurol..

Berkson's paradox and weighted distributions: An application to Alzheimer's disease

P. Alexopoulos, A. Batsidis, P. Economou, 2019, Biometrical journal. Biometrische Zeitschrift.

Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's Disease

W. Klunk, C. Mathis, C. Sorg, 2010, Biological Psychiatry.

Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI

Timo Grimmer, Afra Wohlschläger, Christian Sorg, 2012, European Archives of Psychiatry and Clinical Neuroscience.

Neuroanatomical Correlates of Intelligence in Healthy Young Adults: The Role of Basal Ganglia Volume

Johannes Kornhuber, Arnd Doerfler, Panagiotis Alexopoulos, 2014, PloS one.

Psychological distress in the Greek general population during the first COVID-19 lockdown

P. Alexopoulos, K. Assimakopoulos, K. Karaivazoglou, 2021, BJPsych Open.

Additive sex-specific influence of common non-synonymous DISC1 variants on amygdala, basal ganglia, and white cortical surface area in healthy young adults

J. Kornhuber, A. Doerfler, P. Alexopoulos, 2016, Brain Structure and Function.

Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

Nick C Fox, Alan J. Thomas, D. Hernandez, 2020, Scientific Reports.

Associations between (sub) clinical stress- and anxiety symptoms in mentally healthy individuals and in major depression: a cross-sectional clinical study

G. Iconomou, P. Alexopoulos, K. Assimakopoulos, 2020, BMC Psychiatry.

Diagnostic Potential of Pulsed Arterial Spin Labeling in Alzheimer's Disease

C. Zimmer, C. Preibisch, P. Alexopoulos, 2016, Front. Neurosci..

TBK 1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

F. Jessen, C. Broeckhoven, K. Sleegers, 2019 .

TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

F. Jessen, G. Frisoni, B. Bergmans, 2017, Human mutation.

Soluble Amyloid Precursor Proteins in Blood: Methods and Challenges

R. Perneczky, P. Alexopoulos, 2018 .

Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration

F. Jessen, G. Frisoni, T. Strom, 2014, Acta Neuropathologica.

No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients

B. Bergmans, C. van Broeckhoven, S. Engelborghs, 2018, Neurobiology of Aging.

Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers.

A. Kurz, R. Perneczky, P. Alexopoulos, 2014, Trends in molecular medicine.

P. Lewczuk, Hans Förstl, A. Kurz, 2010, International journal of geriatric psychiatry.

Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease

A. Kurz, R. Perneczky, P. Alexopoulos, 2013, Translational Psychiatry.

COGNITIVE RESERVE, HOMOCYSTEINE, AND COGNITION IN THE BAVARIAN SCHOOL SISTERS STUDY

A. Kurz, R. Perneczky, H. Bickel, 2011, Journal of The American Geriatrics Society.

Plasma Proteomics for the Identification of Alzheimer Disease

Stefan Wagenpfeil, Robert Perneczky, Panagiotis Alexopoulos, 2013, Alzheimer disease and associated disorders.

DETECTION OF SUBCLINICAL STRESS SYMPTOMS WITH THE NEW SSQ-25 QUESTIONNAIRE

G. Iconomou, P. Alexopoulos, K. Assimakopoulos, 2020 .

Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease.

Christoph Laske, Stefanie Dimmeler, Kimon Stamatelopoulos, 2015, Journal of the American College of Cardiology.

May neuropsychiatric symptoms be a potential intervention target to delay functional impairment in Alzheimer’s disease?

P. Alexopoulos, A. Politis, T. Vorvolakos, 2020, International Psychogeriatrics.

The Common Acid Sphingomyelinase Polymorphism p.G508R is Associated with Self-Reported Allergy

J. Kornhuber, S. Schwab, E. Gulbins, 2014, Cellular Physiology and Biochemistry.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C. Fox, Pietro Pietrini, Alexander Gerhard, 2018, Nature Medicine.

Amyloid Precursor Protein Sorting Does the Apolipoprotein E Genotype Influence Amyloid Precursor Protein Sorting by Sortilin‐related Receptor: Implications for Alzheimer's Disease?

Hans Förstl, A. Kurz, R. Perneczky, 2022 .

Altered serum fatty acid composition in geriatric depression

S. Herpertz, G. Irmisch, P. Alexopoulos, 2017, Journal of Neural Transmission.

A standardised methodology for the extraction and quantification of cell-free DNA in cerebrospinal fluid and application to evaluation of Alzheimer's disease and brain cancers.

Alison S. Devonshire, R. Perneczky, C. Foy, 2022, New biotechnology.

Naming ability assessment in neurocognitive disorders: a clinician’s perspective

R. Perneczky, P. Alexopoulos, A. Politis, 2022, BMC Psychiatry.

Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults

Johannes Kornhuber, Thomas Kneib, Robert Perneczky, 2011, Journal of Neural Transmission.

Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.

R. Perneczky, P. Alexopoulos, S. Wagenpfeil, 2017, Journal of Alzheimer's disease : JAD.

miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.

I. Prokopenko, R. Perneczky, E. Evangelou, 2019, Trends in molecular medicine.

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study

K. Blennow, C. van Broeckhoven, S. Engelborghs, 2020, PLoS medicine.

Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

Nick C Fox, Alan J. Thomas, D. Hernandez, 2021, Biological Psychiatry.

Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer’s disease

C. Gieger, A. Peters, D. Rujescu, 2015, Human Genome Variation.

across RNA cell death gene networks is implicated in the semantic variant of primary progressive aphasia.

L. Ferrucci, A. Ramasamy, E. Haan, 2019 .

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

E. Haan, P. Pietrini, R. Petersen, 2017, Scientific Reports.

D. Hernandez, M. Nalls, L. Ferrucci, 2017, bioRxiv.

Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease

R. Perneczky, P. Alexopoulos, Liang-Hao Guo, 2013, European Archives of Psychiatry and Clinical Neuroscience.

Frontotemporal dementia and its subtypes: a genome-wide association study

Alexander Gerhard, Adrian Danek, Luigi Ferrucci, 2014, The Lancet Neurology.

Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment

Timo Grimmer, Hans Förstl, Christian Sorg, 2016, The Journal of Nuclear Medicine.

Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series

C. Potagas, P. Alexopoulos, N. Kokras, 2021, BMC Psychiatry.

CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease

Hans Förstl, A. Kurz, R. Perneczky, 2011, Neurology.

β-Site amyloid precursor protein–cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau

A. Kurz, R. Perneczky, P. Livrea, 2013, Alzheimer's & Dementia.

SORL1 genetic variants and cerebrospinal fluid biomarkers of Alzheimer’s disease

Timo Grimmer, Robert Perneczky, Panagiotis Alexopoulos, 2012, European Archives of Psychiatry and Clinical Neuroscience.

Impact of SORL1 Single Nucleotide Polymorphisms on Alzheimer’s Disease Cerebrospinal Fluid Markers

A. Kurz, R. Perneczky, P. Alexopoulos, 2011, Dementia and Geriatric Cognitive Disorders.

CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum

T. Schneider-Axmann, R. Perneczky, P. Alexopoulos, 2019, Neurobiology of Aging.

Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease

N. Laskaris, A. Drzezga, A. Kurz, 2014, Alzheimer's & Dementia.

Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium

M. Carrillo, J. Molinuevo, E. Karageorgiou, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Fluid biomarker agreement and interrelation in dementia due to Alzheimer’s disease

N. Laskaris, A. Kurz, R. Perneczky, 2017, Journal of Neural Transmission.

Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid

A. Kurz, R. Perneczky, P. Livrea, 2012, Alzheimer's & Dementia.

Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.

Christian Sorg, Stefan Wagenpfeil, Robert Perneczky, 2006, Age and ageing.

Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.

A. Drzezga, A. Kurz, R. Perneczky, 2013, Journal of Alzheimer's disease : JAD.

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease

B. Dubois, M. Sarazin, F. Lamari, 2017, Translational psychiatry.

Mapping CSF biomarker profiles onto NIA–AA guidelines for Alzheimer’s disease

N. Laskaris, A. Kurz, R. Perneczky, 2016, European Archives of Psychiatry and Clinical Neuroscience.

The New Conceptualization of Alzheimer's Disease under the Microscope of Influential Definitions of Disease

A. Kurz, P. Alexopoulos, 2015, Psychopathology.

Determinants of self‐ and carer‐rated quality of life and caregiver burden in Alzheimer disease

R. Perneczky, P. Alexopoulos, Christina Schumann, 2019, International journal of geriatric psychiatry.

Hans Förstl, E. Diamandis, V. Magdolen, 2019, Translational Neurodegeneration.

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex

Hans Förstl, A. Kurz, J. Diehl-Schmid, 2015, Neuropsychiatric disease and treatment.

Progression to Dementia in Clinical Subtypes of Mild Cognitive Impairment

A. Kurz, R. Perneczky, P. Alexopoulos, 2006, Dementia and Geriatric Cognitive Disorders.

Brain size and the compensation of Alzheimer's disease symptoms: A longitudinal cohort study

Stefan Wagenpfeil, Robert Perneczky, Panagiotis Alexopoulos, 2013, Alzheimer's & Dementia.

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

N. Laskaris, A. Kurz, R. Perneczky, 2014, Alzheimer's Research & Therapy.

The National Institute on Aging-Alzheimer’s Association research criteria for mild cognitive impairment due to Alzheimer’s disease: predicting the outcome

A. Kurz, R. Perneczky, P. Alexopoulos, 2013, European Archives of Psychiatry and Clinical Neuroscience.

Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease

M. Tsolaki, K. Sleegers, C. van Broeckhoven, 2017, Acta Neuropathologica.

The Effects of COVID‐19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta‐analysis

M. Barbagallo, A. Koyanagi, P. Soysal, 2022, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

Short-term influence of elevation of plasma homocysteine levels on cognitive function in young healthy adults

J. Kornhuber, T. Kneib, S. Bleich, 2009 .

Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer’s Disease in a Naturalistic Clinical Setting

M. Kliegel, P. Alexopoulos, P. Gourzis, 2021, Journal of Alzheimer's disease : JAD.

Hospital workforce mental reaction to the pandemic in a low COVID-19 burden setting: a cross-sectional clinical study

P. Alexopoulos, K. Assimakopoulos, K. Karaivazoglou, 2021, European Archives of Psychiatry and Clinical Neuroscience.

Associations between APOE-, COMT Val108/158Met- and BDNF Val66Met polymorphisms and variations in depressive and anxiety symptoms, sense of coherence and vital exhaustion in the real-life setting of mandatory basic military training

J. Kornhuber, R. Perneczky, P. Alexopoulos, 2021, Journal of Neural Transmission.

Hot spot identification method based on Andrews curves: an application on the COVID-19 crisis effects on caregiver distress in neurocognitive disorder

P. Alexopoulos, A. Politis, S. Bersimis, 2022, Journal of applied statistics.

Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease

A. Kurz, R. Perneczky, I. Yakushev, 2017, European Archives of Psychiatry and Clinical Neuroscience.

Cerebrospinal fluid BACE1 activity and markers of amyloid precursor protein metabolism and axonal degeneration in Alzheimer's disease

R. Perneczky, P. Alexopoulos, 2014, Alzheimer's & Dementia.

Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease

Yaakov Stern, Christian G. Habeck, Norman L. Foster, 2008, NeuroImage.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Nature Medicine.

DO ALL PATIENTS WITH MILD COGNITIVE IMPAIRMENT PROGRESS TO DEMENTIA?

A. Kurz, R. Perneczky, P. Alexopoulos, 2006, Journal of the American Geriatrics Society.

The overnight reduction of amyloid β 1‐42 plasma levels is diminished by the extent of sleep fragmentation, sAPP‐β, and APOE ε4 in psychiatrists on call

Hans Förstl, A. Kurz, D. Schwerthöffer, 2018, Alzheimer's & dementia : the journal of the Alzheimer's Association.

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Brain : a journal of neurology.

The Differential Role of Executive Apathy in Alzheimer’s Disease Dementia, Mild Cognitive Impairment and Healthy Cognitive Ageing

I. Beratis, P. Alexopoulos, K. Assimakopoulos, 2023, Geriatrics.

Hans Förstl, E. Diamandis, V. Magdolen, 2019, Translational Neurodegeneration.

Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia.

R. Perneczky, B. Hemmer, P. Alexopoulos, 2019, Journal of Alzheimer's disease : JAD.

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

Nick C Fox, D. Hernandez, M. Nalls, 2017, Scientific Reports.

Combined assessment of DYRK 1 A , BDNF and homocysteine levels as diagnostic marker for Alzheimer ’ s disease

B. Dubois, M. Sarazin, F. Lamari, 2018 .

Homocysteine and Cognitive Function in Geriatric Depression

R. Perneczky, S. Bleich, G. Irmisch, 2010, Neuropsychobiology.

Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers.

P. Lewczuk, J. Kornhuber, A. Doerfler, 2011, Journal of Alzheimer's disease : JAD.

Rare Variants in PLD3 Do Not Affect Risk for Early‐Onset Alzheimer Disease in a European Consortium Cohort

M. Tsolaki, K. Sleegers, C. van Broeckhoven, 2015, Human mutation.

Cerebrospinal Fluid Biomarkers of Preclinical Alzheimer’s Disease

P. Alexopoulos, C. Sirinian, 2018 .

Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and 18F-FDG PET.

Christine Preibisch, Stefan Förster, Claus Zimmer, 2018, Radiology.

Interrelations between CSF soluble AβPPβ, amyloid-β 1-42, SORL1, and tau levels in Alzheimer's disease.

A. Kurz, R. Perneczky, J. Diehl-Schmid, 2012, Journal of Alzheimer's disease : JAD.

LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo

C. Sorg, A. Drzezga, Hans Förstl, 2014, NeuroImage: Clinical.

Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study

G. Frisoni, C. Broeckhoven, K. Sleegers, 2015, Neurobiology of Aging.

Small Vessel Disease, but Neither Amyloid Load nor Metabolic Deficit, Is Dependent on Age at Onset in Alzheimer’s Disease

C. Sorg, A. Drzezga, A. Kurz, 2015, Biological Psychiatry.

Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer’s Disease

R. Perneczky, P. Alexopoulos, K. Assimakopoulos, 2018, Dementia and Geriatric Cognitive Disorders.

Timo Grimmer, Hans Förstl, Christian Sorg, 2011, Journal of magnetic resonance imaging : JMRI.

Head circumference, apolipoprotein E genotype and cognition in the Bavarian School Sisters Study

A. Kurz, R. Perneczky, H. Bickel, 2012, European Psychiatry.

The cientificWorldJOURNAL Clinical Study Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer’s Disease

C. Sorg, A. Drzezga, Hans Förstl, 2011 .

Validation of the German Revised Addenbrooke’s Cognitive Examination for Detecting Mild Cognitive Impairment, Mild Dementia in Alzheimer’s Disease and Frontotemporal Lobar Degeneration

Hans Förstl, A. Kurz, A. Danek, 2010, Dementia and Geriatric Cognitive Disorders.

Validation of the Addenbrooke’s Cognitive Examination for Detecting Early Alzheimer’s Disease and Mild Vascular Dementia in a German Population

A. Kurz, S. Herpertz, P. Alexopoulos, 2006, Dementia and Geriatric Cognitive Disorders.

[Validation of a Short Telephone Test (T3MS) for the Diagnosis of Cognitive Impairment].

A. Kurz, R. Perneczky, P. Alexopoulos, 2006, Fortschritte der Neurologie-Psychiatrie.

THE OVERNIGHT REDUCTION OF β-AMYLOID 1-42 PLASMA LEVELS IS DIMINISHED BY THE EXTENT OF SLEEP FRAGMENTATION, SAPP-β AND APOEε4 IN PSYCHIATRISTS ON-CALL

Hans Förstl, A. Kurz, J. Diehl-Schmid, 2018, Alzheimer's & Dementia.

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

N. Laskaris, I. Yakushev, P. Alexopoulos, 2014, Alzheimer's Research & Therapy.

[Comparison of patient therapy adherence of two structural different memory clinics].

H. Lehfeld, P. Alexopoulos, G. Niklewski, 2009, Fortschritte der Neurologie-Psychiatrie.

Validation of the test for finding word retrieval deficits (WoFi) in detecting Alzheimer's disease in a naturalistic clinical setting

R. Perneczky, I. Leroi, P. Alexopoulos, 2023, European Journal of Ageing.

200 - Neuropsychiatric symptoms influence performance of activities of daily living in symptomatic Alzheimer’s Disease

N. Laskaris, P. Alexopoulos, A. Politis, 2021, International Psychogeriatrics.

Influence of brain-derived neurotrophic factor and apolipoprotein E genetic variants on hemispheric and lateral ventricular volume of young healthy adults

P. Lewczuk, J. Kornhuber, A. Doerfler, 2011, Acta Neuropsychiatrica.

Low cognitive functioning and depressive symptoms in patients with rheumatoid arthritis and systemic sclerosis: a clinical study

P. Alexopoulos, P. Gourzis, A. Politis, 2023, BMC Psychiatry.

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease

C. Sorg, A. Drzezga, Hans Förstl, 2012, TheScientificWorldJournal.

Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease

Y. Stern, R. Koeppe, N. Foster, 2008, NeuroImage.

PLASMA HOMOCYSTEINE AND CEREBROSPINAL FLUID NEURODEGENERATION BIOMARKERS IN MILD COGNITIVE IMPAIRMENT AND DEMENTIA

F. Jessen, P. Lewczuk, A. Kurz, 2009, Journal of The American Geriatrics Society.

Plasma homocystein levels in relation to β Amyloid and Tau Protein in cerebrospinal fluid of patients with Mild Cognitive Impairment and Alzheimer's Disease

J. Kornhuber, J. Wiltfang, S. Bleich, 2008 .